Postmortem Findings in Patient with Guillain-Barré Syndrome and Zika Virus Infection

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2017 Dec 21

PMID 29261094

Citations 19

Authors

Emilio Dirlikov

Jose V Torres

Roosecelis Brasil Martines

Sarah Reagan-Steiner

George Venero Perez

Aidsa Rivera

Chelsea Major

Desiree Matos

Jorge Munoz-Jordan

Wun-Ju Shieh

Sherif R Zaki

Tyler M Sharp

Affiliations

Soon will be listed here.

Abstract

Postmortem examination results of a patient with Guillain-Barré syndrome and confirmed Zika virus infection revealed demyelination of the sciatic and cranial IV nerves, providing evidence of the acute demyelinating inflammatory polyneuropathy Guillain-Barré syndrome variant. Lack of evidence of Zika virus in nervous tissue suggests that pathophysiology was antibody mediated without neurotropism.

Citing Articles

Biosafety and mental health: Virus induced cognitive decline.

Du C, Li G, Han G Biosaf Health. 2025; 5(3):159-167.

PMID: 40078510 PMC: 11895046. DOI: 10.1016/j.bsheal.2023.04.002.

An immunoinformatics and structural vaccinology approach to design a novel and potent multi-epitope base vaccine targeting Zika virus.

Hakami M BMC Chem. 2024; 18(1):31.

PMID: 38350946 PMC: 10865692. DOI: 10.1186/s13065-024-01132-3.

Vector-Transmitted Flaviviruses: An Antiviral Molecules Overview.

Diani E, Lagni A, Lotti V, Tonon E, Cecchetto R, Gibellini D Microorganisms. 2023; 11(10).

PMID: 37894085 PMC: 10608811. DOI: 10.3390/microorganisms11102427.

Intrinsic features of Zika Virus non-structural proteins NS2A and NS4A in the regulation of viral replication.

Yu Y, Gao C, Wen C, Zou P, Qi X, Cardona C PLoS Negl Trop Dis. 2022; 16(5):e0010366.

PMID: 35522620 PMC: 9075646. DOI: 10.1371/journal.pntd.0010366.

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response.

Lee L, Komarasamy T, Adnan N, James W, Balasubramaniam V Front Immunol. 2021; 12:750365.

PMID: 34745123 PMC: 8566937. DOI: 10.3389/fimmu.2021.750365.

References

Uncini A, Shahrizaila N, Kuwabara S . Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. 2016; 88(3):266-271. DOI: 10.1136/jnnp-2016-314310. View

Dirlikov E, Major C, Mayshack M, Medina N, Matos D, Ryff K . Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016. MMWR Morb Mortal Wkly Rep. 2016; 65(34):910-4. DOI: 10.15585/mmwr.mm6534e1. View

Parra B, Lizarazo J, Jimenez-Arango J, Zea-Vera A, Gonzalez-Manrique G, Vargas J . Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med. 2016; 375(16):1513-1523. DOI: 10.1056/NEJMoa1605564. View

Cao-Lormeau V, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J . Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016; 387(10027):1531-1539. PMC: 5444521. DOI: 10.1016/S0140-6736(16)00562-6. View

Tomashek K, Rivera A, Torres-Velasquez B, Hunsperger E, Munoz-Jordan J, Sharp T . Enhanced Surveillance for Fatal Dengue-Like Acute Febrile Illness in Puerto Rico, 2010-2012. PLoS Negl Trop Dis. 2016; 10(10):e0005025. PMC: 5058557. DOI: 10.1371/journal.pntd.0005025. View

Arias A, Torres-Tobar L, Hernandez G, Paipilla D, Palacios E, Torres Y . Guillain-Barré syndrome in patients with a recent history of Zika in Cúcuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016. J Crit Care. 2016; 37:19-23. DOI: 10.1016/j.jcrc.2016.08.016. View

Willison H, Jacobs B, van Doorn P . Guillain-Barré syndrome. Lancet. 2016; 388(10045):717-27. DOI: 10.1016/S0140-6736(16)00339-1. View

Hund E, Borel C, Cornblath D, Hanley D, McKhann G . Intensive management and treatment of severe Guillain-Barré syndrome. Crit Care Med. 1993; 21(3):433-46. DOI: 10.1097/00003246-199303000-00023. View

Dirlikov E, Medina N, Major C, Munoz-Jordan J, Luciano C, Rivera-Garcia B . Acute Zika Virus Infection as a Risk Factor for Guillain-Barré Syndrome in Puerto Rico. JAMA. 2017; 318(15):1498-1500. PMC: 5817969. DOI: 10.1001/jama.2017.11483. View

10.

Gerardin P, Cao-Lormeau V, Tournebize P, Cerny T . Letter re: Acute Zika infection with concurrent onset of Guillain-BarrÉ syndrome. Neurology. 2017; 88(19):1874. DOI: 10.1212/WNL.0000000000003927. View

11.

Sejvar J, Kohl K, Gidudu J, Amato A, Bakshi N, Baxter R . Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2010; 29(3):599-612. DOI: 10.1016/j.vaccine.2010.06.003. View

12.

Salinas J, Major C, Pastula D, Dirlikov E, Styczynski A, Luciano C . Incidence and clinical characteristics of Guillain-Barré syndrome before the introduction of Zika virus in Puerto Rico. J Neurol Sci. 2017; 377:102-106. DOI: 10.1016/j.jns.2017.04.006. View

13.

Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira W . Zika Virus and the Guillain-Barré Syndrome - Case Series from Seven Countries. N Engl J Med. 2016; 375(16):1598-1601. DOI: 10.1056/NEJMc1609015. View

14.

Petersen L, Jamieson D, Powers A, Honein M . Zika Virus. N Engl J Med. 2016; 374(16):1552-63. DOI: 10.1056/NEJMra1602113. View